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Treated Mouse Large Intestine
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Escherichia coli F-18, isolated from the feces of a healthy human in 1977, is an excellent colonizer of the
streptomycin-treated mouse large intestine and displays normal motility and chemotaxis ability. A chemotaxis-
defective derivative of E. coli F-18, E. coli F-18 CheA-, and a nonflagellated derivative, E. coli F-18 Fla-, were
constructed. These strains were found to colonize the streptomycin-treated mouse large intestine as well as E.
coli F-18 when mice were fed both E. coli F-18 and either the CheA- or Fla- derivative at high levels (101j CFU
of each strain per mouse) or low levels (104 CFU of each strain per mouse). Furthermore, E. coli F-18 lost
motility and chemotaxis ability when grown in colonic or cecal mucus in vitro despite retaining the ability to
synthesize flagella. Thus, it appears that neither motility nor chemotaxis plays a role in the ability of E. coli F-18
to colonize because this strain becomes functionally nonmotile upon growth in the streptomycin-treated mouse
large intestine.
Evidence is accumulating that the importance of motility,
chemotaxis, or both in the ability of a flagellated intestinal
bacterium to colonize the mammalian intestine depends on
the microorganism, whether the host has a conventional
microflora, is antibiotic treated, or is gnotobiotic, and
whether the microorganism colonizes the small or large
intestine. For example, motility/chemotaxis appears to be
important in the ability of the obligate anaerobe Roseburia
cecicola to colonize the conventional but not the gnotobiotic
mouse cecum (17) and for Vibrio cholerae to infect the
gnotobiotic mouse cecum (8) and ligated loops of conven-
tional rabbit and gnotobiotic mouse small intestine (8).
Moreover, motility also appears to be a colonization factor
for Campylobacter jejuni in the lower small intestine,
cecum, and colon of suckling mice (14) and in the conven-
tional adult rabbit small intestine (3). However, motility/
chemotaxis does not appear to be important in the ability of
Salmonella typhimurium to colonize the large intestines of
conventional (4) or streptomycin-treated (12) mice, nor does
motility appear to be important in the virulence of the
organism (4, 10). Here, we show that motility/chemotaxis
also does not appear to be important in the ability of a human
fecal Escherichia coli strain, F-18, to colonize the mouse
large intestine.
MATERIALS AND METHODS
Bacteria. E. coli F-18 was isolated from the feces of a
healthy human in 1977. A streptomycin-resistant (Strr) and
rifampin-resistant (Rif) derivative of E. coli F-18 is an
excellent colonizer of the streptomycin-treated mouse large
intestine (6). The strain produces type 1 pili and colicin V,
and its serotype is rough:K1:H5 (11). E. coli F-18 (Strr Rif'
Nalr) is a spontaneous nalidixic acid-resistant (Nalr) mutant
of E. coli F-18 (Strr Rif) which in cofeeding experiments
colonizes the streptomycin-treated mouse large intestine as
well as its parent. E. coli F-18 (Strr Rif) will hereafter be
referred to as E. coli F-18.
* Corresponding author.
Nonchemotactic derivatives of E. coli F-18 (i.e., non-
spreading on semisolid L motility agar and nontumbling but
motile microscopically) were selected on L-agar plates con-
taining tetracycline (10 ,ug/ml) after bacteriophage P1
cotransduction of a defective cheA gene and a closely linked
TnJO insertion from E. coli RP1781 into E. coli F-18, as
described previously (11). TnWO was lost from the
nonchemotactic transductants at high frequency in the ab-
sence of tetracycline selection (90% loss in 10 generations);
however, the tetracycline-sensitive segregants remained
nonchemotactic. A spontaneous Nalr mutant was selected
from one such nonchemotactic E. coli F-18 segregant as
described previously (6) and designated E. coli F-18 CheA-.
In cofeeding experiments, E. coli F-18 CheA- (Strr Rif' Nalr)
colonized the streptomycin-treated mouse large intestine as
well as its nalidixic acid-sensitive CheA- parent. Further-
more, it grew in Davis broth minimal (Difco Laboratories,
Detroit, Mich.) with glucose as the sole source of carbon, as
does E. coli F-18. E. coli RP1781 does not grow in this
medium.
Nonflagellated derivatives of E. coli F-18 were selected on
L-agar plates containing streptomycin (100 ,ug/ml), rifampin
(50 ,ug/ml), and kanamycin (40 ,ug/ml) after P1 transduction
from an E. coli MC1000 strain that contains a kanamycin
cassette in the flhD gene, making it nonflagellated. All
kanamycin-resistant (Kan) colonies were Strr Rif' and non-
motile (i.e., nonspreading on semisolid L motility agar and
showing only Brownian motion microscopically). One col-
ony was selected for further work and was designated E. coli
F-18 Fla-. E. coli F-18 Fla- also grew in Davis broth
minimal with glucose as the sole source of carbon. E. coli
MC1000 does not grow in this medium.
Media and antibiotics. L broth was made as described by
Revel (16). L agar is L broth containing 12 g of Bacto-
Agar (Difco) per liter. MacConkey agar (Difco) was pre-
pared according to package instructions. L motility agar
is L broth containing 3.5 mg of Bacto-Agar per ml of water.
Cecal mucus motility agar is cecal mucus (2 mg of protein
per ml in N- hydroxyethylpiperazine - N' - 2 - ethanesulfonic
acid [HEPES]-Hanks buffer, pH 7.4) containing 3.5 mg of
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Difco agar purified per ml of water. In some experiments, L
motility and cecal mucus motility agars were supplemented
with adenosine 3',5'-cyclic AMP (cAMP; Sigma Chemical
Co., St. Louis, Mo.) to a final concentration of 2 mM.
Mouse colonization experiments. The method used to dis-
tinguish the relative colonizing abilities of E. coli strains in
mice has been described in detail previously (6, 11). Briefly,
after 1 day of being fed streptomycin sulfate in their drinking
water (5 g/liter), three male CD-1 mice (5 to 8 weeks old)
were starved from 18 to 24 h for food (Charles River Valley
Rat, Mouse, and Hamster Formula) and water and fed either
1010 or 104 CFU each of the L-broth-grown E. coli strains to
be tested in 1 ml of sterile 20% (wt/vol) sucrose, as described
previously (6, 11). The mice drank the bacterial suspension
almost immediately and were then given food and strepto-
mycin-containing drinking water. The next day and at 48-h
intervals, fecal samples, no older than 24 h, were collected,
homogenized, diluted, and plated on selective media as
described below. In all colonization experiments, plates
were incubated at 37°C for 18 to 24 h. Colonizing ability was
assessed by the level at which a strain persisted in feces.
Each experiment was performed at least twice, with essen-
tially identical results.
To differentiate between E. coli F-18 (Strr Rif) and E. coli
F-18 CheA- (Strr Rif' Nalr), fecal samples were plated on
MacConkey agar containing 100 ,ug of streptomycin sulfate
and 50 ,ug of rifampin per ml and on MacConkey agar
containing 100 ,ug of streptomycin sulfate, 50 pLg of rifampin,
and 50 ,g of nalidixic acid per ml. The numbers of E. coli
F-18 CheA- were determined directly from the plates con-
taining nalidixic acid. The numbers of E. coli F-18 were
determined each day by transferring by toothpick 50 colo-
nies from the plates without nalidixic acid to plates contain-
ing nalidixic acid and determining the fraction of the total
that was nalidixic acid sensitive. The numbers of E. coli F-18
CheA- per gram of feces calculated from the results of
toothpick transfer agreed very well with the numbers deter-
mined from direct plating.
To differentiate E. coli F-18 (Strr Rifr Nalr) from E. coli
F-18 Fla- (Strr Rif' Kanr), fecal samples were plated on
MacConkey agar containing 100 ,ug of streptomycin sulfate,
50 ,ug of rifampin, and 50 ,ug of nalidixic acid per ml and on
MacConkey agar containing 100 ,ug of streptomycin sulfate,
50 ,ug of rifampin, and 40 ,g of kanamycin monosulfate per
ml.
Microscopic observation of E. coli F-18 grown in intestinal
mucus in vitro. Jejunal, cecal, proximal colonic, midcolonic,
and distal colonic mucus preparations (2 mg of protein per
ml) were prepared from male CD-1 mice (5 to 8 weeks old) in
HEPES-Hanks buffer, pH 7.4, as described previously (6,
12, 19). E. coli F-18 in HEPES-Hanks buffer, pH 7.4, was
inoculated into each mucus preparation at about 104 CFU
per ml and incubated standing for 18 h at 37°C. E. coli F-18
routinely grew to about 108 CFU per ml in each preparation.
Uninoculated mucus preparations remained bacteria free
when examined microscopically. As a control, L broth was
inoculated with 104 CFU of E. coli F-18 per ml. Routinely, E.
coli F-18 grew to about 2 x 108 CFU/ml upon standing for 18
h at 37°C. Wet mounts were examined for motility by
phase-contrast microscopy under oil at x 1,000 magnifica-
tion.
Viable counts of E. coli F-18 in the intestinal mucus of
streptomycin-treated mice colonized with E. coil F-18. Three
streptomycin-treated mice were each fed 1010 CFU of E. coli
F-18. Eight days later the mice were sacrificed, and the
jejunal, cecal, proximal colonic, midcolonic, and distal co-
lonic mucus of each mouse was scraped separately into 5 ml
of HEPES-Hanks buffer, pH 7.4. Each preparation was then
homogenized and plated on L agar containing 100 ,ug of
streptomycin sulfate and 50 ,ug of rifampin per ml. The plate
counts were then corrected to the 5-ml volume to determine
the total E. coli F-18 CFU present in each undiluted mucus
sample.
Spread of E. coli F-18 on L motility and mucus motility
agars. Three E. coli F-18 colonies, isolated from the jeju-
num, cecum, proximal colon, midcolon, and distal colon of
each streptomycin-treated mouse colonized for 8 days with
E. coli F-18, were streaked on L agar containing streptomy-
cin sulfate (100 ,ug/ml) and rifampin (50 ,ug/ml), incubated at
37°C for 18 h, transferred by toothpick to L motility agar,
and incubated at 37°C for 18 h. At that time, the diameter of
spread of each colony was measured in millimeters.
In another experiment, E. coli F-18 was freshly streaked
as described above and transferred by toothpick to L motil-
ity, jejunal mucus motility, cecal mucus motility, proximal
colon mucus motility, midcolon mucus motility, and distal
mucus motility agars and to each of these motility agars
containing 2 mM cAMP. Incubation was at 37°C for 18 h,
after which the diameters of spread were measured in
millimeters.
Motility of cecal mucus-grown E. coli F-18 suspended in L
broth. E. coli F-18 grown in cecal mucus as described above
was centrifuged at room temperature at 3,000 x g for 5 min,
washed once in HEPES-Hanks buffer, pH 7.4, and sus-
pended at the same concentration in L broth. Similarly, E.
coli F-18 grown in L broth was centrifuged, washed, and
suspended in fresh cecal mucus (2 mg per ml of protein in
HEPES-Hanks buffer, pH 7.4) and in spent cecal mucus,
i.e., cecal mucus centrifuged free of E. coli F-18 that had
grown in it. Motility of E. coli F-18 in each preparation was
observed microscopically as described above.
Electron microscopy. Bacterial suspensions in either L
broth or cecal mucus were stained for 10 s with 1% phos-
photungstic acid as described by Arthur et al. (1) on copper
grids coated with Formvar and carbon. The samples were
examined in a JEOL 1200 SX microscope.
Chemicals. All chemicals were reagent grade.
RESULTS
Relative colonizing abilities of E. coli F-18, E. coli F-18
Fla-, and E. coli F-18 CheA-. When E. coli F-18 (Strr Rif'
Nalr) and E. coli F-18 Fla- (Strr Rif' Kan) were fed
simultaneously (1010 CFU each) to streptomycin-treated
mice, both colonized the large intestine in equal numbers,
i.e., approximately 5 x 107 CFU/g of feces (Fig. 1). Each
day, several presumptive Fla- colonies were tested for
motility on L motility agar, and all remained nonmotile. Both
E. coli F-18 and E. coli F-18 CheA- also cocolonized the
streptomycin-treated mouse large intestine, i.e., each at
about 5 x 107 CFU/g of feces (data not shown). Several E.
coli F-18 CheA- colonies were tested each day as described
above, and all remained nonchemotactic.
To determine whether motility/chemotaxis might be im-
portant when small numbers of E. coli F-18 are fed to mice,
streptomycin-treated mice were fed 104 CFU of E. coli F-18
and E. coli F-18 Fla-. Both strains grew rapidly in the
streptomycin-treated mouse large intestine and cocolonized
at about 108 CFU/g of feces (Table 1). Again, essentially
identical results were obtained when 104 CFU each of E. coli
F-18 and E. coli F-18 CheA- was fed to streptomycin-
treated mice (data not shown). E. coli F-18 Fla- and E. coli
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FIG. 1. Relative colonizing abilities ofE. cc
and E. coli F-18 Fla- (Stri Rif' Kanr). Three
mice were fed 1010 CFU each of E. coli F-18
Fla- (0). Symbols and bars represent the lc
CFU per gram of feces and standard error
respectively.
F-18 CheA- colonies isolated from feces
the duration of the experiments remair
nonchemotactic, respectively.
Motility after growth in intestinal mi
grows well in cecal mucus but poorl)
contents in vitro (19), suggesting that E. c
nutrition for growth in and colonization o
treated mouse large intestine from intesi
E. coli F-18 was grown overnight in L br
motile; however, when grown in mucus
protein per ml isolated from either the
colon, midcolon, or distal colon, E. coli I
and did not show any translational swi
When grown in jejunal mucus, E. coli F-:
but observable tumbling and swimming a
When E. coli F-18 was transferred by
agar to L motility agar, it spread rap
normal motility/chemotaxis activity (9)
trast, when E. coli F-18 was transferred b
agar to mucus motility agar made from ei
proximal colonic, midcolonic, or distal
grew but did not spread (Table 2). Furth(
2 mM cAMP to each of the motility agar X
in increased spreading (Table 2). Typica
TABLE 1. Relative colonizing abilities o1
E. coli F-18 Fla- in streptomycin-trea
104 CFU of each strain
TABLE 2. Diameter of spread of E. coli F-18 on
intestinal mucus motility agars
Diam of E. coli F-18 spread
Type of (mean + SE)'
motility agar
Unsupplemented +2 mM cAMP
L 29.5 ± 0.5 29.5 ± 0.5
Jejunal 9.3 + 0.8 11.5 ± 0.5
Cecal 8.0 ± 1.0 6.5 ± 0.5
Proximal colonic 8.3 ± 0.3 8.8 ± 0.8
Midcolonic 7.0 ± 1.0 7.8 ± 0.3
Distal colonic 9.5 ± 0.5 7.5 ± 0.5
a Spread of E. coli F-18 on the various motility agars was performed in
duplicate, and measurements were made after incubation at 37'C for 18 h.
F-18 on L motility agar and cecal mucus motility agar is
illustrated in Fig. 2.
11 13 15 It might be argued that E. coli F-18 was nonmotile after
growth in intestinal mucus because mucus is too viscous to
allow normal tumbling and swimming. However, when E.
1i F-18 (StiF Rif' Nalr) coli F-18 grown in L broth was centrifuged and suspended in
streptomycin-treated cecal mucus (2 mg/ml with respect to protein), it remained as
(), and E. coli F-18 motile as in L broth, suggesting that mucus viscosity was not
)g10 mean number of responsible for the loss of E. coli F-18 tumbling and swim-
r of the loglo mean, ming activity when the cells were grown in cecal mucus.
Furthermore, E. coli F-18 grown in L broth and suspended in
spent cecal mucus also retained full tumbling and swimming
at all times during activity.
ied nonmotile and Numbers and motility of E. coli F-18 in intestinal mucus
throughout the intestine. Mucus isolated from the jejunum,
ucus. E. coli F-18 cecum, proximal colon, midcolon, and distal colon of strep-
y in cecal luminal tomycin-treated mice colonized with E. coli F-18 for 8 days
roli F-18 derives its was assayed for the numbers of E. coli F-18 in each
tf the streptomycin- preparation (Table 3). The cecal and proximal colonic mucus
tinal mucus. When preparations contained about equal numbers of E. coli F-18
oth, it was actively (Table 3). Twenty times fewer E. coli F-18 were found in the
containing 2 mg of jejunal mucus preparation, and two to three times fewer
cecum, proximal were found in the midcolonic and distal colonic mucus
F-18 did not tumble preparations (Table 3). E. coli F-18 colonies isolated from
Mmiing movement. each of the mucus preparations proved to be just as motile as
18 showed reduced E. coli F-18 that had not been in a mouse (Table 3).
ictivity. Electron microscopy of E. coli F-18 grown in L broth and
( toothpick from L cecal mucus. E. coli F-18 cells grown in L broth and in cecal
idly, indicative of mucus were examined by electron microscopy for the pres-
(Table 2). In con- ence of flagella. Of 150 L-broth-grown E. coli F-18 cells
y toothpick from L examined, 30 (20%) had flagella. Similarly, of 98 cecal
ither jejunal, cecal, mucus-grown E. coli F-18 cells examined, 18 (18%) had
colonic mucus, it flagella. Since all L-broth-grown cells are motile when
ermore, addition of
plates did not result
i spread of E. coli
f E. coli F-18 and
ated mice fed
Loglo no. of CFU/g of feces (mean ± SE)'
Day
E. coli F-18 E. coli F-18 Fla-
1 7.93 ± 0.92 8.01 ± 0.74
3 8.43 + 0.36 8.57 ± 0.37
5 7.90 ± 0.28 8.04 + 0.20
a Three streptomycin-treated mice were each fed 104 CFU of E. coli F-18
and 104 CFU of E. coli F-18 Fla-. Fecal samples were diluted and plated as
described in the text.
FIG. 2. Spread of E. coli F-18 on L motility agar (a) and cecal
mucus motility agar (b) after 12 h of incubation at 37°C.
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TABLE 3. Determination of numbers and motility of E. coli F-18
isolated from intestinal mucus in vivo'
Intestine CFU (105) per Diam of spread
section section (mean ± SE) (mean mm ± SE)b
Jejunum 3.5 ± 2.2 24.9 ± 2.8
Cecum 56.7 ± 16.6 21.1 ± 3.1
Proximal colon 58.2 ± 28.7 26.4 ± 2.3
Midcolon 26.6 ± 18.7 29.8 ± 3.1
Distal colon 15.9 ± 7.0 21.6 ± 2.1
a Mucus preparations were isolated from three mice colonized with E. coli
F-18.
b Three colonies from each section of each mouse were tested for spread on
L motility agar. The diameter of spread of E. coli Fla- in this experiment was
7.2 ± 0.3 mm.
viewed by phase-contrast microscopy, it appears likely that
preparation of specimens for electron microscopy shears
flagella from E. coli F-18. In any case, these data suggest that
the cecal mucus-grown E. coli F-18 cells were indeed flag-
ellated.
DISCUSSION
We have previously used the streptomycin-treated mouse
as a model for large intestine colonization of nonpathogenic
gram-negative bacteria and have shown it to be a sensitive
tool. For example, lipopolysaccharide-defective mutants of
an avirulent S. typhimurium strain will not colonize when fed
to streptomycin-treated mice together with their smooth
parent, although they colonize at normal levels (i.e., about 5
x 107 CFU/g of feces) when fed to mice alone (12, 15).
Furthermore, we have shown that a derivative of E. coli
F-18, E. coli F-18 Col-, cannot grow in mouse cecal mucus
in vitro in the presence of its parent, although it grows well
when inoculated alone and cannot colonize the streptomy-
cin-treated mouse when fed together with its parent, but
colonizes in normal numbers when fed to mice alone (6, 19).
Moreover, we have shown that E. coli F-18 settles to the
bottom of culture tubes when grown in nutrient broth
containing glucose (1%, wt/wt) and that a nonsettling mu-
tant, E. coli F-18 Set-, is a poor colonizer of the streptomy-
cin-treated mouse large intestine when fed to mice together
with its parent but not when fed to mice alone (5). These
results suggest that the streptomycin-treated mouse large
intestine can be used to determine whether a specific defect
either in E. coli F-18 or in avirulent S. typhimurium strains
renders them poor colonizers or has no effect on their
colonizing abilities and therefore whether the wild-type
bacterial component involved is or is not a major coloniza-
tion factor. It would, of course, be better if we could avoid
the use of streptomycin; however, in this case the presence
of the normal facultative flora prevents colonization of
incoming microorganisms (2, 7, 18).
In this investigation, we have shown that motility/chemo-
taxis ability does not appear to be a colonization factor for E.
coli F-18. That is, both a nonflagellated and a nonchemotac-
tic derivative of E. coli F-18 colonized the streptomycin-
treated mouse large intestine as well as E. coli F-18 when
either strain was fed to mice together with E. coli F-18 (Fig.
1 and Table 1).
We have previously shown that the ability of E. coli F-18
to colonize appears to depend on its ability to grow in large
intestine mucus (19), and here we have shown that as E. coli
F-18 grows in large intestine mucus in vitro, it becomes
nonmotile (Fig. 2 and Table 2). If the same is true in vivo,
i.e., growth in mucus renders E. coli F-18 nonmotile, the
reason that motility/chemotaxis plays no role in E. coli F-18
colonization is clear. Unfortunately, it is difficult to ascertain
whether E. coli F-18 is nonmotile in mucus in vivo, since it
is an extremely small part of the total large intestine mucus
flora in streptomycin-treated mice. It should be noted,
however, that microscopic examination of the large intestine
mucus flora in streptomycin-treated mice reveals that many
of the microorganisms are motile and many are nonmotile
(unpublished observations).
Flagellar synthesis in E. coli is catabolite repressible and
as such is relieved by the addition ofcAMP (13). In the study
presented here, addition of 2 mM cAMP did not cause
increased E. coli F-18 spread on cecal or colonic mucus
motility agar plates (Table 2), suggesting that glucose or
glucoselike components present in large intestine mucus
were not inhibiting E. coli F-18 flagellar synthesis. Indeed, as
determined by electron microscopy, E. coli F-18 grown in
cecal mucus was flagellated, suggesting the possibility that
mucus viscosity limited E. coli F-18 movement. However,
this also appears not to be the case, since actively motile E.
coli F-18 grown in L broth remained fully motile when
suspended in either fresh or spent cecal mucus, and E. coli
F-18 grown in cecal mucus remained nonmotile when sus-
pended in L broth. Therefore, when grown in cecal mucus,
E. coli F-18 acts as if it has paralyzed flagella, a phenotype
previously described (13).
Finally, we do not know how E. coli F-18 travels through
mucus in vivo in a nonmotile state to initiate the colonization
process. It is possible, however, that as water is resorbed in
the intestine to form the fecal pellets found in the proximal
colon, E. coli F-18 Fla- or CheA- cells are passively taken
into the mucus layer, where they can then replicate and
colonize.
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